Compass Therapeutics, Inc. (CMPX)
0.9912
+0.01
(+0.79%)
USD |
NASDAQ |
Oct 09, 16:00
0.9912
0.00 (0.00%)
After-Hours: 19:11
Compass Therapeutics Max Drawdown (5Y) : 90.91% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 90.91% |
| August 31, 2026 | 90.91% |
| July 31, 2026 | 90.91% |
| June 30, 2026 | 90.91% |
| May 31, 2026 | 90.91% |
| April 30, 2026 | 90.91% |
| March 31, 2026 | 90.91% |
| February 28, 2026 | 90.91% |
| January 31, 2026 | 90.91% |
| Date | Value |
|---|---|
| December 31, 2025 | 90.91% |
| November 30, 2025 | 90.91% |
| October 31, 2025 | 90.91% |
| September 30, 2025 | 90.91% |
| August 31, 2025 | 90.91% |
| July 31, 2025 | 90.91% |
| June 30, 2025 | 90.91% |
| May 31, 2025 | 90.91% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Viking Therapeutics, Inc. | 89.26% |
| Capricor Therapeutics, Inc. | 91.80% |
| Ardelyx, Inc. | 95.65% |
| Biomea Fusion, Inc. | 97.71% |
| ARS Pharmaceuticals, Inc. | 95.20% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.16 |
| Beta (5Y) | 0.9226 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 93.69% |
| Historical Sharpe Ratio (5Y) | -0.266 |
| Historical Sortino (5Y) | -0.5053 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.96% |